explore -WSS

explore

author：focus 2025-09-29 01:45:37 - browse：69

Daniel M. Skovronsky on stage at the 2023 STAT Summit. — Dan Skovronsky, Eli Lilly's chief scientific officer, at the 2023 STAT Summit. STAT

PHILADELPHIA — In a sense, the annual meeting of the American Heart Association wasn’t a huge one for Eli Lilly. Its biggest news was about a very early study of a drug to lower blood levels of Lp(a), a protein related to cholesterol that is mainly being watched by lipidologists and drug company analysts.

But in another way, the future of Lilly, now the biggest drug company by market capitalization, hung in the balance. Why? Because researchers were presenting data on the ability of Novo Nordisk’s obesity drug Wegovy to prevent heart attacks, strokes, and deaths in people with overweight who have established cardiovascular disease. That has big implications for the market for Lilly’s own obesity drug, Zepbound, which was approved by the Food and Drug Administration last week, and for the company’s future efforts in obesity.

STAT sat down with Lilly’s chief scientific officer, Dan Skovronsky, at the AHA meeting to talk about the obesity drugs known as GLP-1s, the new Lp(a) drug, and the company’s partnership with the gene editing firm Verve. An edited transcript of the conversation follows.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Prime Medicine says its gene editing passes test in monkeys

Wikipedia

knowledge

WSS

Key Senate panel to consider PBM, drug pricing reform package

Travis Kelce and the trap of celebrity vaccine endorsements

Travis Kelce and the trap of celebrity vaccine endorsements

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Inari Medical to buy amputation prevention company LimFlow

R1 RCM gets $5.8 billion buyout offer from private equity firm

hotspot

explore

entertainment

Guidelines to prevent youth baseball injuries need more muscle

Dario to buy mental health app maker Twill in cash and stock deal

Anesthesiologist group: stop taking Ozempic before surgery

In utero gene editing: an explainer

In age of alternative facts, a scholarly course on calling out crap

Brain injuries and the importance of a second opinion

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Medicare proceeds with plan to claw back hospital funds

Apple is now the first public company to be valued at $3 trillion

Dario to buy mental health app maker Twill in cash and stock deal

knowledge

Bill would allow buprenorphine prescription for addiction via telehealth

The health care issue Democrats can’t solve: hospital reform

Community Health Systems hospitals under DOJ investigation

Infant mortality in U.S. rose last year for first time in decades: CDC

Alabama IVF ruling threatens families facing fatal genetic disease

Key Senate panel to consider PBM, drug pricing reform package

Wikipedia

knowledge

Wikipedia

leisure time